Trade Summary

2 days ago, Talasaz Amirali, serving as Co-CEO at Guardant Health, Inc. (GH), sold 50,000 shares at $100.32 per share, for a total transaction value of $5,016,000.00. Following this transaction, Talasaz Amirali now holds 2,096,504 shares of GH.

This sale represents a 2.00% decrease in Talasaz Amirali's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 1 day after the trade was made.

Guardant Health, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.